Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
BAC Bank of America Corp
INCT Incapta Inc
HAYN Haynes International Inc
MLSS Milestone Scientific Inc
IMKTA Ingles Markets Inc
III Information Services Group Inc
HVRRY Hannover Rueck SE
HVRRF Hannover Rueck SE
HNFSB Hanover Foods Corp
Go

Health Care : Biotechnology | Large Cap ValueCompany profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Closing Price
$65.07
Day's Change
1.26 (1.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
65.22
Day's Low
64.00
Volume
(Above Average)
Volume:
6,908,607

10-day average volume:
5,840,693
6,908,607
  • Prev Close
    63.81
  • Today's Open
    64.16
  • Day's Range
    64.00-65.22
  • Avg Vol (10-day)
    5.8M
  • Last (time)
    4:15p ET 11/15/19
  • Last (size)
    1
  • 52-Wk Range
    60.32 - 72.90
    LowHigh
  • (12/03/18 - 12/26/18)
    7.87%
  • 22.6%
  • Market Cap
    82.3B
  • Shares Outstanding
    1.3B
  • 2.11
  • 30.91x
  • $2.52/3.87%
  • Ex-dividend
    12/12/19
  • 1.1
  • 80.62
  • (% of float 10/31/19)
    1.18

Latest News

November 09, 2019
4:30 pm ET
BusinessWire
November 08, 2019
8:06 pm ET
BusinessWire
8:07 am ET
BusinessWire
8:07 am ET
BusinessWire
8:07 am ET
BusinessWire
November 07, 2019
1:54 pm ET
MarketWatch
November 06, 2019
9:00 am ET
BusinessWire
6:45 am ET
BusinessWire
6:45 am ET
BusinessWire
November 05, 2019
9:00 am ET
PR Newswire
October 31, 2019
4:01 pm ET
BusinessWire
7:17 am ET
BusinessWire
October 28, 2019
8:00 am ET
BusinessWire
October 25, 2019
7:49 am ET
MarketWatch
October 24, 2019
4:22 pm ET
MarketWatch
4:02 pm ET
BusinessWire
4:01 pm ET
BusinessWire
11:47 am ET
MarketWatch
October 17, 2019
12:45 pm ET
PR Newswire
October 15, 2019
8:48 am ET
MarketWatch
8:30 am ET
BusinessWire
October 12, 2019
12:26 pm ET
MarketWatch
October 10, 2019
6:00 pm ET
BusinessWire
4:05 pm ET
BusinessWire
October 08, 2019
8:30 am ET
PR Newswire
2:00 am ET
BusinessWire
October 07, 2019
8:40 am ET
MarketWatch
8:33 am ET
MarketWatch
8:30 am ET
BusinessWire
October 04, 2019
8:30 am ET
BusinessWire
October 03, 2019
2:49 pm ET
BusinessWire
October 01, 2019
9:05 am ET
PR Newswire
September 30, 2019
9:00 am ET
PR Newswire
September 27, 2019
12:31 pm ET
MarketWatch
September 10, 2019
9:00 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.